poisar

Stocks · News reference

On Aug 19, Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement; Pipe Financing Minimum Of $15M Not Raised By Aug 21, 2026; Closing Conditions Not Met

BenzingaBenzinga Newsdesk

On August 19, 2026, Mangoceuticals, Inc. (the "Company" or "MGRX") and Nuclea Energy Inc. ("Nuclea") mutually agreed to terminate that certain Business Combination Agreement, dated as of July 29,

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — MANGOCEUTICALS, INC. (MGRX)

    Filed: 2026-08-21 AccNo: 0001493152-26-039724 Size: 248 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits